Basilea Pharmaceutica AG (LON:0QNA)

Revenue by Product

Financials in millions CHF. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005
Innovative Pharmaceutical Products	208.54M
Innovative Pharmaceutical Products Growth	32.30%

Revenue by Geography

Financials in millions CHF. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005
Ireland	93.70M
Ireland Growth	36.39%
Japan	69.60M
Japan Growth	16.78%
United States	12.30M
United States Growth	101.64%
Uruguay	12.10M
Uruguay Growth	18.63%
Canada	6.70M
Canada Growth	86.11%
United Kingdom	4.60M
Jordan	4.60M
Jordan Growth	155.56%
Sweden	2.30M
Sweden Growth	-41.03%
China	2.30M
China Growth	0%
Other	400.00K